CLGN
NASDAQ · Biotechnology
Collplant Biotechnologies Lt
$4.64
+0.68 (+17.17%)
Open$4.05
Previous Close$3.96
Day High$4.64
Day Low$4.05
52W High$22.50
52W Low$2.64
Volume—
Avg Volume47.1K
Market Cap8.77M
P/E Ratio—
EPS$-9.39
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+270.5% upside
Current
$4.64
$4.64
Target
$17.19
$17.19
$14.35
$17.19 avg
$29.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.67M | 1.84M | 1.91M |
| Net Income | -17,801,515 | -8,043,256 | 134.3K |
| Profit Margin | -484.6% | -460.3% | 7.0% |
| EBITDA | -16,379,050 | -7,811,686 | 222.2K |
| Free Cash Flow | — | — | 168.1K |
| Rev Growth | +99.2% | +99.2% | +10.4% |
| Debt/Equity | — | — | 0.39 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |